Home › Halozyme Therapeutics: Even After Doubling, Shares Have Upside
 

Keywords :   


Halozyme Therapeutics: Even After Doubling, Shares Have Upside

2015-06-03 17:10:52| Biotech - Topix.net

The rally has been powered by myriad positive catalysts including positive trials and collaboration deals with other players in the biotech space. It has been quite a while since I provided an update on one of my favorite biotech stocks, Halozyme Therapeutics .

Tags: have shares upside doubling

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »